MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target

MLA

Damian Jacenik, et al. “MK2 Drives Progression of Pancreas and Colon Cancers by Suppressing CD8+ T Cell Cytotoxic Function and Is a Potential Immunotherapy Target.” Frontiers in Immunology, vol. 14, June 2023. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1212100.

APA

Damian Jacenik, Eric J. Lebish, & Ellen J. Beswick. (2023). MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212100

Chicago

Damian Jacenik, Eric J. Lebish, and Ellen J. Beswick. 2023. “MK2 Drives Progression of Pancreas and Colon Cancers by Suppressing CD8+ T Cell Cytotoxic Function and Is a Potential Immunotherapy Target.” Frontiers in Immunology 14 (June). doi:10.3389/fimmu.2023.1212100.